Nicolas Pauillac
Stock Analyst at Kepler Capital
(4.67)
# 829
Out of 4,581 analysts
377
Total ratings
52.1%
Success rate
17.5%
Average return
Main Sectors:
Stocks Rated by Nicolas Pauillac
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Upgraded: Buy | 1,500p → 2,516p | 2,029p | +24.00% | 2 | May 26, 2026 | |
| SWX: COPN Cosmo N.V. | Maintained: Buy | CHF 130.00 | CHF 63.00 | +106.35% | 35 | May 11, 2026 | |
| SWX: SDZ Sandoz Group AG | Maintained: Buy | CHF 80.00 | CHF 65.04 | +23.00% | 29 | May 11, 2026 | |
| EPA: CVX Carvolix SA | Maintained: Buy | €5.00 | €5.54 | -9.75% | 30 | May 4, 2026 | |
| EPA: OSE OSE Immunotherapeutics SA | Maintained: Buy | €8.20 | €3.17 | +159.00% | 40 | Apr 30, 2026 | |
| SWX: IDIA Idorsia Ltd | Maintained: Buy | CHF 4.50 | CHF 6.65 | -32.33% | 1 | Apr 28, 2026 | |
| SWX: BION BB Biotech AG | Maintained: Buy | CHF 66.00 → CHF 73.00 | CHF 51.60 | +41.47% | 15 | Apr 24, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €85.00 | €79.38 | +7.08% | 16 | Apr 23, 2026 | |
| ETR: FYB Formycon AG | Maintained: Buy | €33.00 | €18.90 | +74.60% | 51 | Apr 22, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 280.00 | kr 324.49 | -13.71% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €20.30 | €13.69 | +48.28% | 34 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €36.60 | €25.24 | +45.01% | 33 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €5.00 | €2.72 | +83.82% | 8 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €15.00 | €7.52 | +99.47% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €390.00 | €345.50 | n/a | 19 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €0.80 → €0.64 | €0.02 | n/a | 21 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $90 → $47 | $28.15 | n/a | 2 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €79.00 → €41.00 | €24.70 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $389 → $426 | $872.23 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €342.00 → €375.00 | €768.00 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.43 | n/a | 3 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 57.00 | CHF 51.80 | n/a | 10 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.00 | €2.80 | n/a | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €7.50 → €9.00 | €2.19 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €17.00 | €4.47 | n/a | 1 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €0.60 → €0.40 | €0.75 | n/a | 4 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €2.70 | €0.38 | n/a | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | €3.96 | n/a | 1 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.00 | €108.80 | n/a | 1 | Dec 21, 2022 |
GSK plc
May 26, 2026
Upgraded: Buy
Price Target: 1,500p → 2,516p
Current: 2,029p
Upside: +24.00%
Cosmo N.V.
May 11, 2026
Maintained: Buy
Price Target: CHF 130.00
Current: CHF 63.00
Upside: +106.35%
Sandoz Group AG
May 11, 2026
Maintained: Buy
Price Target: CHF 80.00
Current: CHF 65.04
Upside: +23.00%
Carvolix SA
May 4, 2026
Maintained: Buy
Price Target: €5.00
Current: €5.54
Upside: -9.75%
OSE Immunotherapeutics SA
Apr 30, 2026
Maintained: Buy
Price Target: €8.20
Current: €3.17
Upside: +159.00%
Idorsia Ltd
Apr 28, 2026
Maintained: Buy
Price Target: CHF 4.50
Current: CHF 6.65
Upside: -32.33%
BB Biotech AG
Apr 24, 2026
Maintained: Buy
Price Target: CHF 66.00 → CHF 73.00
Current: CHF 51.60
Upside: +41.47%
Sanofi
Apr 23, 2026
Maintained: Hold
Price Target: €85.00
Current: €79.38
Upside: +7.08%
Formycon AG
Apr 22, 2026
Maintained: Buy
Price Target: €33.00
Current: €18.90
Upside: +74.60%
Novo Nordisk A/S
Apr 20, 2026
Maintained: Hold
Price Target: kr 280.00
Current: kr 324.49
Upside: -13.71%
Apr 1, 2026
Maintained: Buy
Price Target: €20.30
Current: €13.69
Upside: +48.28%
Mar 6, 2026
Maintained: Buy
Price Target: €36.60
Current: €25.24
Upside: +45.01%
Feb 25, 2026
Maintained: Buy
Price Target: €5.00
Current: €2.72
Upside: +83.82%
Sep 25, 2025
Maintained: Hold
Price Target: €15.00
Current: €7.52
Upside: +99.47%
Jul 17, 2025
Maintained: Hold
Price Target: €390.00
Current: €345.50
Upside: n/a
May 6, 2024
Maintained: Sell
Price Target: €0.80 → €0.64
Current: €0.02
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $90 → $47
Current: $28.15
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: €79.00 → €41.00
Current: €24.70
Upside: n/a
Feb 20, 2024
Maintained: Hold
Price Target: $389 → $426
Current: $872.23
Upside: n/a
Feb 20, 2024
Maintained: Hold
Price Target: €342.00 → €375.00
Current: €768.00
Upside: n/a
Jan 10, 2024
Maintained: Buy
Price Target: $14
Current: $1.43
Upside: n/a
Nov 20, 2023
Maintained: Buy
Price Target: CHF 57.00
Current: CHF 51.80
Upside: n/a
Sep 7, 2023
Maintained: Buy
Price Target: €16.00
Current: €2.80
Upside: n/a
Aug 28, 2023
Upgraded: Buy
Price Target: €7.50 → €9.00
Current: €2.19
Upside: n/a
Jun 22, 2023
Maintained: Buy
Price Target: €17.00
Current: €4.47
Upside: n/a
May 3, 2023
Maintained: Buy
Price Target: €0.60 → €0.40
Current: €0.75
Upside: n/a
Apr 28, 2023
Maintained: Buy
Price Target: €2.70
Current: €0.38
Upside: n/a
Dec 29, 2022
Maintained: Buy
Price Target: €12.00
Current: €3.96
Upside: n/a
Dec 21, 2022
Maintained: Buy
Price Target: €16.00
Current: €108.80
Upside: n/a